This page contains a limited version of this dossier in the EU Monitor.
official titleProposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease
|Decision making procedure||ordinary legislative procedure (COD)|
|reference by COM-number i||COM(2020)261|
|procedure number i||2020/0128(COD)|
|CELEX number i||52020PC0261|
|Decision||15-07-2020; Verordening 2020/1043|
|Publication in Official Journal i||17-07-2020; OJ L 231 p. 12-16|
This page is also available in a full version containing the latest state of affairs, the summary of the European Parliament Legislative Observatory, the legal context, other dossiers related to the dossier at hand, the stakeholders involved (e.g. European Commission directorates-general, European Parliament committees, Council configurations and even individual EU Commissioners and Members of the European Parliament) and finally documents of the European Parliament, the Council of Ministers and the European Commission.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals the newly added documents and subsequent meetings in which these are scheduled for discussion or vote. The latest state of affairs is conveniently presented in such a way that a single glance is sufficient to keep informed. By way of alerts through e-mail or digital newsletters users and their clients are kept in the loop 24/7.If you are interested in the EU Monitor, please contact us at firstname.lastname@example.org.